Company DescriptionLinc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.

How the Company Makes Money

Linc AB Financial Statement Overview

Summary

Linc AB demonstrates a strong equity position and no leverage, providing a stable financial foundation. However, volatility in profitability metrics and inconsistent cash flow generation present challenges. The company needs to focus on stabilizing its profitability and improving cash flow reliability to enhance its financial performance.

Income Statement

Neutral

Linc AB shows strong growth in revenue over recent years, with a notable increase from 2023 to 2024. However, profitability metrics present a mixed picture. The gross profit and net profit margins are high for 2024, yet there are inconsistencies with previous years, reflecting volatility. EBIT and EBITDA margins are also strong for 2024, but the historical performance shows periods of negative margins, indicating instability in the company's operational efficiency.

Balance Sheet

Positive

The balance sheet for Linc AB is strong with a solid equity base and no debt in 2024. The debt-to-equity ratio is zero, highlighting low financial risk. The equity ratio is high, indicating that the company is well-capitalized. However, previous years show some liabilities, though they remain minimal relative to equity, indicating robust financial health over time.

Cash Flow

Negative

Cash flow analysis reveals challenges, with volatility in operating cash flow and free cash flow over recent years. While there is positive free cash flow in 2024, prior years show significant negative cash flows, reflecting instability in cash generation. The operating cash flow to net income ratio suggests inconsistency in converting income into cash, posing risks to liquidity management.

TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Breakdown
Income Statement		Total Revenue
5.01M	1.29B	3.65M	2.37M	4.14M	1.31M
	Gross Profit
-5.39M	1.29B	904.00K	-2.66M	-2.44M	-1.19M
	EBIT
2.24B	1.28B	648.65M	-898.43M	-37.14M	970.05M
	EBITDA
-815.74M	0.00	666.10M	9.75M	-9.67M	0.00
	Net Income Common Stockholders
244.33M	1.30B	619.46M	-723.34M	-30.03M	833.18M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
519.98M	549.66M	519.98M	600.55M	828.69M	21.91M
	Total Assets
3.53B	4.84B	3.53B	2.91B	3.76B	2.64B
	Total Debt
0.00	0.00	4.48M	287.00K	127.00K	255.00K
	Net Debt
-519.98M	-549.66M	-519.98M	-600.26M	-828.57M	-21.65M
	Total Liabilities
2.92M	8.76M	2.92M	2.85M	130.48M	144.17M
	Stockholders Equity
3.53B	4.83B	3.53B	2.91B	3.63B	2.49B
Cash Flow		Free Cash Flow
157.37M	29.68M	-80.57M	-228.15M	-353.84M	-14.63M
	Operating Cash Flow
157.37M	29.68M	-80.57M	-228.15M	-353.84M	-14.63M
	Investing Cash Flow
1.09B	0.00	0.00	-199.75M	-339.45M	-6.38M
	Financing Cash Flow
-19.33M	0.00	0.00	-5.00M	1.16B	-7.65M

Linc AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (64)

Financial Indicators

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6ZB		€377.56M	19.65	5.76%	―	―	―
Sector *	64 Neutral	$12.85B	9.81	7.59%	16985.65%	12.30%	-7.71%
1W6		€366.39M	105.00	7.13%	0.28%	―	―
BLZ		€1.97B	360.93	0.27%	0.91%	―	―
7EU		€10.06M	―	-24.32%	―	―	―
SKD		€566.89M	14.51	7.27%	2.80%	―	―
61MA		€600.76M	33.51	16.42%	―	―	―

* Financial Sector Average

Performance Comparison

DE:6ZB

Linc AB

6.49

-1.50

-18.77%

DE:1W6

Idun Industrier AB Class B

31.50

12.75

68.00%

DE:BLZ

Bure Equity AB

26.42

-5.79

-17.98%

DE:7EU

Vo2 Cap Holding AB

0.13

-0.09

-40.91%

DE:SKD

Svolder AB Class B

5.32

-0.25

-4.49%

DE:61MA

MedCap AB

39.85

-8.65

-17.84%

Glossary

OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.

NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.

UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.